Quantcast

Spiro PD Reduces ER Visits and Healthcare Costs

July 9, 2012

Monitoring lung function with Spiro PD personal spirometer has been decreasing direct and indirect healthcare costs associated with chronic lung disease.

Allentown, PA (PRWEB) July 09, 2012

On Thursday, June 28th, The U.S. Supreme Court declared the Patient Protection and Affordable Care Act constitutional. Healthcare costs are on the rise. It is now more important than ever to find ways to reduce expenses associated with healthcare. Spiro PD personal spirometer has been decreasing direct and indirect healthcare costs associated with chronic lung disease. Spiro PD promotes prevention and early detection which reduces expensive emergency room visits, hospital admissions and missed work days.

Spiro PD is the world´s first truly personal spirometer. It empowers patients with lung diseases — those with asthma, COPD, Cystic Fibrosis and lung transplants — to easily, accurately, and affordably monitor their lung function anytime and anywhere. It tracks lung function trends and can alert a patient of a decline in lung function before symptoms occur. This helps anticipate and prevent COPD exacerbations and asthma attacks, and reduces expensive emergency room visits and hospital stays.

According to the Center for Disease Control and Prevention, COPD is the third leading cause of death in America. Each year COPD and asthma combined account for approximately 1,170,000 hospitalizations. Asthma costs the US government approximately $56 billion each year. According to the National Heart, Lung, and Blood Institute, COPD cost the U.S. government approximately $42.6 billion in both direct and indirect expenses in 2007. A majority of those expenses are due to ER visits and hospitalizations, which can be prevented with ongoing home monitoring and better medication adherence. Monitoring lung function on a regular basis with Spiro PD gives patients objective lung function data and puts them in control of their disease. It eliminates guessing the severity of one´s condition and allows patients to be proactive with their care and avoid expensive emergency room visits.

Gary Toulouse is a 64 year old resident of Bay City Michigan who loves devoting his time to his family and spends the summers boating. He is also the recipient of a double lung transplant which he received in April of 2010. Gary uses Spiro PD every day to monitor the condition of his lungs and once a week he uploads the data from Spiro PD to his computer and emails the reports to his doctors. When Gary was asked how Spiro PD has affected his life, his response was “There can be enormous complications for lung transplant recipients. The possibility of a rapid lung function decline without feeling symptoms right away is extreme. Monitoring my lung function on a daily basis with Spiro PD gives me a remarkable piece of mind. I did not go through all of this and neither did the 19 year old who donated their lungs to me so that I could spend the rest of my life in a doctor´s office or hospital. I was given this gift so that I could make the most out of my life and spend my time with my family. By knowing the exact condition of my lung function and helping to avoid hospital admissions, Spiro PD helps me do just that.”

Spiro PD was developed by PMD Healthcare. Headquartered in Allentown, Pennsylvania the company is dedicated to creating innovative, easy-to-use, portable and affordable personal medical devices, and to empower people world-wide to improve their healthcare and quality of life. For more information about Spiro PD, please visit http://www.SpiroPD.com or call 464-664-7600.

Spiro PD can also be found on these social media sites:

FaceBook: http://www.facebook.com/SpiroPD

Twitter: http://www.twitter.com/SpiroPD

YouTube: http://www.youtube.com/SpiroPD

Spiro PD Blog: http://www.spiropd.com/blog

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/7/prweb9679253.htm


Source: prweb



comments powered by Disqus